Tag: "novantrone" at medical news

FDA advisory committee recommends approval of novantrone for treatment of worsening multiple sclerosis

.GAITHERSBURG, MD -- NOVANTRONE (mitoxantrone for injection concentrate) was unanimously recommended for approval to slow the worsening of neurologic disability and to reduce the relapse rate in patients with clinically worsening forms of relapsing-remitting and secondary progressive multiple sclerosis (MS). This recommendation was made today by the U.S. Food and Drug Administration (FDA) Perip...

NOVANTRONE application for multiple sclerosis granted priority review by FDA

. .SEATTLE-Immunex Corporation (NASDAQ:IMNX) announced today that the U.S. Food and.Drug Administration (FDA) has assigned priority review status to the new drug.application (NDA) for NOVANTRONER (mitoxantrone for injection concentrate),.indicating that the FDA will act on the application within six months of its.date of submission. Immunex filed for expanded labeling for NOVANTRONE for the.tre...

Immunex Files Supplemental NDA for NOVANTRONE

. . .SEATTLE - Immunex Corporation (NASDAQ:IMNX) announced today that it has filed a.supplemental NDA with the U.S. Food and Drug Administration (FDA) for expanded.labeling for NOVANTRONE® (mitoxantrone for injection concentrate) for the.treatment of patients with secondary progressive Multiple Sclerosis (MS).. . "There are 120,000 patients with secondary progressive MS for whom there...

New Three Year Follow-up Data Of Novantrone In Multiple Sclerosis

. Positive Response and Safety Profile of NOVANTRONE Confirmed over a Three Year.Period.In Study Treating People with Secondary Progressive Multiple Sclerosis . .TORONTO, ONTARIO, CANADA - Patients with secondary progressive multiple.sclerosis (MS) treated with NOVANTRONER (mitoxantrone for injection concentrate).experienced sustained reduction in their number of attacks, and delay in their.disa...